Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa Response Profiling in PD
NCT06275633Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Mar 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-blind trial of levodopa in Parkinson's disease (PD) (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Motor improvement (UPDRS). Started Mar 2019; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06275633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06275633.